Edition:
United States

Chimerix Inc (CMRX.OQ)

CMRX.OQ on NASDAQ Stock Exchange Global Market

5.02USD
2:41pm EST
Change (% chg)

$0.05 (+1.01%)
Prev Close
$4.97
Open
$4.97
Day's High
$5.04
Day's Low
$4.97
Volume
23,383
Avg. Vol
81,028
52-wk High
$6.63
52-wk Low
$4.18

Select another date:

Fri, Feb 9 2018

BRIEF-Arrowmark Colorado Holdings Llc Reports 5.7 PCT Passive Stake In Chimerix As Of Dec 31, 2017

* ARROWMARK COLORADO HOLDINGS LLC REPORTS 5.7 PERCENT PASSIVE STAKE IN CHIMERIX INC AS OF DECEMBER 31, 2017 - SEC FILING‍​ Source text - (http://bit.ly/2EeZ3kp) Further company coverage:

BRIEF-Chimerix Initiates Adapt Study For Oral Brincidofovir

* CHIMERIX INITIATES ADAPT STUDY FOR ORAL BRINCIDOFOVIR AND ADVANCES IV BRINCIDOFOVIR TO PATIENT STUDIES Source text for Eikon: Further company coverage:

BRIEF-Chimerix reports Q3 loss of $0.37/shr

* Q3 earnings per share view $-0.43 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

BRIEF-Chimerix Inc files for mixed shelf of up to $250 million

* Files for mixed shelf of up to $250 million - SEC filing‍​ Source text : (http://bit.ly/2m8BtgL) Further company coverage:

BRIEF-Chimerix Inc entered into agreement with Cowen and Co

* On November 8, 2017, co entered into an at market issuance, or ATM, sales agreement with Cowen and Company LLC - SEC filing​

BRIEF-Chimerix Inc appoints Heather Knight-Trent vice president of regulatory affairs

* Chimerix appoints Heather Knight-Trent, PHARMD, as vice president of regulatory affairs Source text for Eikon: Further company coverage:

Select another date: